Immunotherapy leverages the body's own immune system to fight cancer. One of the most promising forms of immunotherapy is checkpoint inhibitors, which work by blocking proteins that prevent the immune system from attacking cancer cells. Another form, CAR-T cell therapy, involves extracting T cells from a patient, genetically modifying them to target cancer cells, and then reintroducing them into the patient’s body. This personalized approach has shown remarkable success in treating certain types of cancers, such as leukemia and lymphoma.
